1. Modified recombinant human IgG1‐Fc is superior to natural intravenous immunoglobulin at inhibiting immune‐mediated demyelination. Issue 1 (9th May 2021) Authors: Baksmeier, Christine; Blundell, Pat; Steckel, Julia; Schultz, Verena; Gu, Quan; Da Silva Filipe, Ana; Kohl, Alain; Linnington, Chris; Lu, Dongli; Dell, Anne; Haslam, Stuart; Wang, Jiabin; Czajkowsky, Dan; Goebels, Norbert; Pleass, Richard J. Journal: Immunology Issue: Volume 164:Issue 1(2021) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗